Medidata Supports White House Cancer Moonshot Effort
Medidata is supporting the White House Cancer Moonshot initiative by working with the National Cancer Institute (NCI) to enroll patients in the Cancer Moonshot Biobank.
The Cancer Moonshot Biobank relies on Medidata’s Patient Cloud and Rave solutions, including eConsent and Rave EDC (electronic data capture).
Read more about Medidata's involvement here.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Optimizing Phase III Oncology Trial Recruitment with Data-Driven Insights
February 3rd 2025A pharmaceutical company aimed to launch a Phase III clinical trial for a new oncology drug, focusing on efficient and effective patient recruitment across diverse regions. They evaluated patient populations by analyzing demographics, social determinants of health, and geography. Investigator profiling included practice details, affiliations, referral networks, and clinical trial experience. The final step involved selecting and extracting target lists for implementation.
